SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharma - Quaterly Results

12 Feb 2022 Evaluate
The Total revenue for the quarter ended December 2021 of  Rs. 330.02 millions remain, more or less, the same.Profit after tax improved marginally to Rs. 62.26  millions for the quarter ended December 2021 from Rs. 59.46 millions of corresponding previous quarter.The company reported a good operating profit of 82.58 millions compared to 80.67 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 330.02 318.19 3.72 956.90 797.35 20.01 1092.94 1188.91 -8.07
Other Income 12.85 10.50 22.38 36.71 30.49 20.40 43.08 42.18 2.13
PBIDT 82.58 80.67 2.37 262.72 178.63 47.07 241.52 239.63 0.79
Interest 1.01 1.17 -13.68 3.13 3.53 -11.33 4.74 5.26 -9.89
PBDT 81.57 79.50 2.60 259.59 175.10 48.25 236.78 234.37 1.03
Depreciation 4.73 5.08 -6.89 13.61 15.08 -9.75 20.35 22.99 -11.48
PBT 76.84 74.42 3.25 245.98 160.02 53.72 216.43 211.38 2.39
TAX 14.58 14.96 -2.54 57.51 33.77 70.30 51.39 62.68 -18.01
Deferred Tax -0.42 1.46 -128.77 -1.77 -3.58 -50.56 -3.91 3.69 -205.96
PAT 62.26 59.46 4.71 188.47 126.25 49.28 165.04 148.70 10.99
Equity 45.89 45.89 0.00 45.89 45.89 0.00 45.89 45.89 0.00
PBIDTM(%) 25.02 25.35 -1.30 27.46 22.40 22.55 22.10 20.16 9.64

Jenburkt Pharma Share Price

1025.60 6.35 (0.62%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×